The Board proposes the development of rule amendments to address the requirements of the recently enacted Section 456.0131, F.S., with regard to the prescribing of controlled substances for the treatment of acute pain.
RULE NO.:RULE TITLE:
64B15-14.005Standards for the Use of Controlled Substances for Treatment of Pain
PURPOSE AND EFFECT: The Board proposes the development of rule amendments to address the requirements of the recently enacted Section 456.0131, F.S., with regard to the prescribing of controlled substances for the treatment of acute pain.
SUBJECT AREA TO BE ADDRESSED: The prescribing of controlled substances for the treatment of acute pain.
RULEMAKING AUTHORITY: 456.0131, 459.005(1) FS.
LAW IMPLEMENTED: 456.0131, 459.003(3), 459.015(1)(g), (x), (2) FS.
IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE REGISTER.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Kama Monroe, J.D., Executive Director, Board of Osteopathic Medicine/MQA, 4052 Bald Cypress Way, Bin #C06, Tallahassee, Florida 32399-3256.
THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS NOT AVAILABLE.
Document Information
- Subject:
- The prescribing of controlled substances for the treatment of acute pain.
- Purpose:
- The Board proposes the development of rule amendments to address the requirements of the recently enacted Section 456.0131, F.S., with regard to the prescribing of controlled substances for the treatment of acute pain.
- Rulemaking Authority:
- 456.0131, 459.005(1) FS.
- Law:
- 456.0131, 459.003(3), 459.015(1)(g), (x), (2) FS.
- Contact:
- Kama Monroe, J.D., Executive Director, Board of Osteopathic Medicine/MQA, 4052 Bald Cypress Way, Bin #C06, Tallahassee, Florida 32399-3256.
- Related Rules: (1)
- 64B15-14.005. Standards for the Use of Controlled Substances for Treatment of Pain